News

INEOS NOVA is planing to close the polystyrene (PS) plant at Breda, Netherlands. The plant has a capacity of 90,000 tonne/year with 50 employees. The company said that

Arkema has announced the construction of a carbon nanotube (CNT) pilot production plant at its Mont site (France, Pyrenees-Atlantiques). The 400ton/year plant, scheduled for startup in the beginning

Wound Management Technologies has completed the acquisition of BioPharma Management Technologies, a privately held biotechnology company with a platform of proprietary and patented technologies for topical pain management

Edifecs has extended its Edifecs5010 Compliance Suite offering by adding the new Edifecs5010 Comparison Manual, an analysis resource that provides side-by-side comparisons of the 4010A1 and 5010 HIPAA

The Wellcome Trust and Merck & Co. have announced the creation of the MSD Wellcome Trust Hilleman Laboratories, a not-for-profit research and development joint venture to focus on

imaGenes will provide service offerings with BioTrove’s OpenArray Platform, a nanoliter Real-Time qPCR, allowing for about 9,000 assays simultaneously. Reportedly, OpenArray produces faster results, allowing gene expression profiling,

InVitria has launched Optiferrin, a high performance, well-defined and animal-free recombinant transferrin for use in mammalian cell culture. Optiferrin is a cell culture supplement which supports cell growth

APP Pharmaceuticals, a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals, has received approval from the FDA to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine

Genentech has announced that a phase III study (PRIMA) showed that patients with follicular lymphoma who continued receiving Rituxan (rituximab) alone after responding to Rituxan and chemotherapy lived